JP2008510764A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008510764A5 JP2008510764A5 JP2007528755A JP2007528755A JP2008510764A5 JP 2008510764 A5 JP2008510764 A5 JP 2008510764A5 JP 2007528755 A JP2007528755 A JP 2007528755A JP 2007528755 A JP2007528755 A JP 2007528755A JP 2008510764 A5 JP2008510764 A5 JP 2008510764A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- therapeutic compound
- sensitive therapeutic
- granules
- moisture sensitive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60532704P | 2004-08-27 | 2004-08-27 | |
| US60/605,327 | 2004-08-27 | ||
| US61682804P | 2004-10-07 | 2004-10-07 | |
| US60/616,828 | 2004-10-07 | ||
| PCT/EP2005/009252 WO2006021455A1 (en) | 2004-08-27 | 2005-08-26 | Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008510764A JP2008510764A (ja) | 2008-04-10 |
| JP2008510764A5 true JP2008510764A5 (https=) | 2008-10-09 |
| JP5147399B2 JP5147399B2 (ja) | 2013-02-20 |
Family
ID=35447883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007528755A Expired - Lifetime JP5147399B2 (ja) | 2004-08-27 | 2005-08-26 | 湿気感受性薬剤の溶融顆粒を含む即時放出型組成物およびその製造法 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20080050443A1 (https=) |
| EP (2) | EP3087975A1 (https=) |
| JP (1) | JP5147399B2 (https=) |
| KR (8) | KR20220061249A (https=) |
| CN (1) | CN101010068B (https=) |
| AR (1) | AR050615A1 (https=) |
| AU (1) | AU2005276583B2 (https=) |
| BR (1) | BRPI0514682B8 (https=) |
| CA (1) | CA2575499A1 (https=) |
| DK (1) | DK1786401T3 (https=) |
| ES (1) | ES2647671T3 (https=) |
| HU (1) | HUE034653T2 (https=) |
| MX (1) | MX2007002253A (https=) |
| MY (1) | MY144297A (https=) |
| PE (1) | PE20060652A1 (https=) |
| PL (1) | PL1786401T3 (https=) |
| PT (1) | PT1786401T (https=) |
| RU (1) | RU2383332C2 (https=) |
| SI (1) | SI1786401T1 (https=) |
| TW (1) | TWI402082B (https=) |
| WO (1) | WO2006021455A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2766487C2 (ru) | 2004-01-20 | 2022-03-15 | Новартис Аг | Композиция и способ прямого прессования |
| AU2005210285B2 (en) | 2004-02-05 | 2008-01-24 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| AR050615A1 (es) | 2004-08-27 | 2006-11-08 | Novartis Ag | Composiciones farmaceuticas para la administracion oral |
| EP1995237A4 (en) | 2006-03-08 | 2011-07-06 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF |
| WO2007128801A1 (en) * | 2006-05-08 | 2007-11-15 | Novartis Ag | Combination of organic compounds |
| WO2008114857A1 (ja) | 2007-03-22 | 2008-09-25 | Kyorin Pharmaceutical Co., Ltd. | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
| DE102008020701A1 (de) * | 2008-04-24 | 2009-10-29 | Bayer Technology Services Gmbh | Formulierung mit reduzierter Hygroskopizität |
| WO2010016584A1 (ja) * | 2008-08-07 | 2010-02-11 | 杏林製薬株式会社 | ビシクロ[２．２．２]オクチルアミン誘導体の製造方法 |
| KR20110044780A (ko) * | 2008-08-14 | 2011-04-29 | 교린 세이야꾸 가부시키 가이샤 | 안정화된 의약 조성물 |
| AR073651A1 (es) * | 2008-09-24 | 2010-11-24 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
| CN102438617A (zh) | 2009-03-27 | 2012-05-02 | 杏林制药株式会社 | 含有碱性添加剂的基质型缓释制剂 |
| JP2011057586A (ja) * | 2009-09-08 | 2011-03-24 | Kyorin Pharmaceutical Co Ltd | ｐＨ非依存性マトリックス型徐放性製剤 |
| TR201002256A1 (tr) * | 2010-03-24 | 2011-10-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Stabil aliskiren formülasyonları |
| US8989577B2 (en) | 2012-06-21 | 2015-03-24 | Qualcomm Incorporated | Methods and systems for implementing time-division duplexing in the physical layer |
| US9071358B2 (en) | 2012-06-21 | 2015-06-30 | Qualcomm Incrorporated | Repeater fiber-coax units |
| US9363017B2 (en) | 2012-07-06 | 2016-06-07 | Qualcomm Incorporated | Methods and systems of specifying coaxial resource allocation across a MAC/PHY interface |
| JP6283316B2 (ja) * | 2012-10-26 | 2018-02-21 | 株式会社三和化学研究所 | アナグリプチン含有固形製剤 |
| US10369108B2 (en) * | 2013-03-15 | 2019-08-06 | Mylan Laboratories, Inc. | Hot melt granulation formulations of poorly water-soluble active agents |
| CN104274408A (zh) * | 2013-07-10 | 2015-01-14 | 北京科信必成医药科技发展有限公司 | 一种熔融包衣的速释药物微粒及其制备方法 |
| US20150366813A1 (en) * | 2014-06-20 | 2015-12-24 | Banner Life Sciences Llc | Liquid-filled immediate release soft gelatin capsules |
| PL3512505T3 (pl) | 2016-09-16 | 2023-08-07 | Galenicum Health S.L.U. | Farmaceutyczne kompozycje wildagliptyny |
| CN117695279A (zh) * | 2023-11-28 | 2024-03-15 | 九华华源药业(桂林)有限公司 | 氯雷他定组合物及氯雷他定药物 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109770A0 (en) | 1993-05-29 | 1994-11-28 | Smithkline Beecham Corp | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby |
| WO1995005808A1 (en) * | 1993-08-24 | 1995-03-02 | Abbott Laboratories | Oil-based tableting method |
| PT654263E (pt) | 1993-11-23 | 2002-06-28 | Euro Celtique Sa | Metodo para a preparacao de uma composicao de libertyacao prolongada |
| IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| US20020142037A1 (en) | 1996-10-01 | 2002-10-03 | Nabil Farah | Process for the manufacture of a pharmaceutical composition with modified release of active principle comprising a matrix |
| WO1998018763A1 (en) | 1996-10-25 | 1998-05-07 | Tanabe Seiyaku Co., Ltd. | Tetrahydroisoquinoline derivatives |
| US6011155A (en) | 1996-11-07 | 2000-01-04 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| CA2302275C (en) * | 1997-09-19 | 2009-12-08 | Shire Laboratories, Inc. | Solid solution beadlet |
| DE19823831A1 (de) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| US6107317A (en) | 1999-06-24 | 2000-08-22 | Novartis Ag | N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| US20020015730A1 (en) | 2000-03-09 | 2002-02-07 | Torsten Hoffmann | Pharmaceutical formulations and method for making |
| SK10802003A3 (sk) | 2001-02-02 | 2004-05-04 | Takeda Chemical Industries, Ltd. | Kondenzovaná heterocyklická zlúčenina, jej použitie a jej farmaceutický prípravok |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US7985422B2 (en) * | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
| AU2003262059A1 (en) * | 2002-09-11 | 2004-04-30 | Takeda Pharmaceutical Company Limited | Sustained release preparation |
| CA2502269C (en) | 2002-10-18 | 2009-12-22 | Merck & Co., Inc. | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| ATE469645T1 (de) | 2002-10-23 | 2010-06-15 | Bristol Myers Squibb Co | Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv |
| AR050615A1 (es) | 2004-08-27 | 2006-11-08 | Novartis Ag | Composiciones farmaceuticas para la administracion oral |
-
2005
- 2005-08-25 AR ARP050103558A patent/AR050615A1/es not_active Application Discontinuation
- 2005-08-25 PE PE2005000979A patent/PE20060652A1/es not_active Application Discontinuation
- 2005-08-26 WO PCT/EP2005/009252 patent/WO2006021455A1/en not_active Ceased
- 2005-08-26 KR KR1020227013566A patent/KR20220061249A/ko not_active Withdrawn
- 2005-08-26 BR BRPI0514682A patent/BRPI0514682B8/pt active IP Right Grant
- 2005-08-26 CN CN2005800289311A patent/CN101010068B/zh not_active Expired - Fee Related
- 2005-08-26 MY MYPI20054015A patent/MY144297A/en unknown
- 2005-08-26 KR KR1020197001094A patent/KR20190006612A/ko not_active Ceased
- 2005-08-26 KR KR1020077004461A patent/KR20070049646A/ko not_active Ceased
- 2005-08-26 RU RU2007110953/15A patent/RU2383332C2/ru active
- 2005-08-26 JP JP2007528755A patent/JP5147399B2/ja not_active Expired - Lifetime
- 2005-08-26 KR KR1020167002363A patent/KR20160017123A/ko not_active Withdrawn
- 2005-08-26 US US11/573,658 patent/US20080050443A1/en not_active Abandoned
- 2005-08-26 AU AU2005276583A patent/AU2005276583B2/en not_active Ceased
- 2005-08-26 KR KR1020137009959A patent/KR101613775B1/ko not_active Expired - Fee Related
- 2005-08-26 SI SI200532179T patent/SI1786401T1/sl unknown
- 2005-08-26 KR KR1020167032323A patent/KR20160136465A/ko not_active Withdrawn
- 2005-08-26 PT PT57750671T patent/PT1786401T/pt unknown
- 2005-08-26 EP EP16169370.0A patent/EP3087975A1/en not_active Ceased
- 2005-08-26 PL PL05775067T patent/PL1786401T3/pl unknown
- 2005-08-26 KR KR1020177024422A patent/KR20170103039A/ko not_active Ceased
- 2005-08-26 MX MX2007002253A patent/MX2007002253A/es active IP Right Grant
- 2005-08-26 ES ES05775067.1T patent/ES2647671T3/es not_active Expired - Lifetime
- 2005-08-26 EP EP05775067.1A patent/EP1786401B1/en not_active Expired - Lifetime
- 2005-08-26 DK DK05775067.1T patent/DK1786401T3/da active
- 2005-08-26 CA CA002575499A patent/CA2575499A1/en not_active Abandoned
- 2005-08-26 HU HUE05775067A patent/HUE034653T2/hu unknown
- 2005-08-26 TW TW094129377A patent/TWI402082B/zh not_active IP Right Cessation
- 2005-08-26 KR KR1020207019819A patent/KR20200087870A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008510764A5 (https=) | ||
| RU2007110953A (ru) | Композиция с быстрым высвобождением лекарственного средства, включающая гранулы чувствительного к влаге лекарственного средства, полученная гранулированием из расплава, и способ ее получения | |
| US7374779B2 (en) | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents | |
| ES2731881T3 (es) | Composiciones que comprenden compuestos activos lipófilos y método para su preparación | |
| CN100341493C (zh) | 用于延时和受控释放药物活性成分的微粒口服盖仑制剂 | |
| RU2240786C2 (ru) | Пероральные лекарственные формы пролонгированного действия | |
| JP5723289B2 (ja) | 持続放出医薬製剤 | |
| CN110721164B (zh) | 匹莫苯的改善的药物组合物 | |
| US20030180352A1 (en) | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions | |
| CN1423555A (zh) | 掩蔽味道的涂料组合物 | |
| HRP20151383T1 (hr) | Farmaceutski pripravci koji sadrže nilotinib ili njegovu sol | |
| HK1046244A1 (en) | Controlled release and taste masking oral pharmaceutical compositions | |
| CN1976682A (zh) | 用于延时和控制释放药物活性成分的微粒口服盖仑制剂 | |
| RU2005131492A (ru) | Саше месалазина с высокой нагрузкой лекарства | |
| JP2005506336A5 (https=) | ||
| JP2006514100A5 (https=) | ||
| JP2011148816A (ja) | 口腔内速崩壊性錠 | |
| IL145559A (en) | METHODS FOR THE PREPARATION OF A MEDICAL PREPARATION CONTAINING TOLPRISON FOR ORAL ADMINISTRATION | |
| CN103919715A (zh) | 含有甘磷酸胆碱或其盐的控释药物组合物及其制备方法 | |
| JPH06510532A (ja) | 医薬品組成物の製造法 | |
| JP2005533751A5 (https=) | ||
| CN101330904A (zh) | 含有低熔点活性成分的固体分散体以及含有它的口服给药片剂 | |
| JP5297194B2 (ja) | 初期溶解率が改善されたプランルカスト固体分散体の薬剤学的組成物およびその製造方法 | |
| CN1044591A (zh) | 一种水分散二甲苯氧庚酸组合物的制备方法 | |
| CN102234265A (zh) | 兰索拉唑化合物 |